Artificial intelligence is being used to create stronger strains of cannabis in a bid to find the most effective MMJ.
Firms across Europe and the US are currently producing a raft of cannabis products – with the industry expected to be worth £32 billion by 2024.Cultivators are utilising AI to monitor conditions like plant temperature and to prevent crop failure – with some of the processes almost entirely automated.
Stephen Murphy, Co-Founder & Managing Director at Prohibition Partners, believes the approach could revolutionise the industry and the applications of the drug.
Mr Murphy, whose firm advises cannabis companies and government bodies, told the Daily Star: “The industry is at the forefront of developing personalised medicines and being able to engineer those medicines based on the individual’s health history and how they’re reacting to different formulations.
Read more at dailystar.co.uk
